Oragenics appoints Natasha Giordano to board of directors effective Sept 1, 2025

ORAGENICS INC

Natasha Giordano appointed to Oragenics Board effective September 1, 2025.
Ms. Giordano brings experience from PLx Pharma (CEO), Matinas BioPharma board, and HCA.
She will receive annual base director fee of $45,000, pro-rated, and $3,750/month for Sept-Dec 2025.
She has agreed to stand for re-election at next annual meeting of shareholders.

item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-25-012562
form_type: 8-K
ticker: OGEN
cik: 0001174940
company_name: ORAGENICS INC
filed_at: 2025-09-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.489592+00:00
generated_at: 2026-05-17T08:44:33.260356+00:00
sec_items: ["5.02", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-25-012562
json_url: https://secwatch.observer/filing/0001493152-25-012562.json
markdown_url: https://secwatch.observer/filing/0001493152-25-012562.md
text_url: https://secwatch.observer/filing/0001493152-25-012562.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315225012562/0001493152-25-012562-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315225012562/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-25-012562

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.